On June 24, 2026 in San Francisco, Assort Health disclosed a $120 million Series C funding round, with Menlo Ventures as the leader, valuing the company at $1.2 billion. The AI agents platform for patient journey has accumulated over $222 million in total funding to establish itself as the industry standard.